🇺🇸 FDA
Patent

US 8697079

IgE antibodies for the treatment of cancer

granted A61PA61P35/00A61P37/04

Quick answer

US patent 8697079 (IgE antibodies for the treatment of cancer) held by The Regents of the University of California expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61P, A61P35/00, A61P37/04